Solution

Despite recent progress in medicine, numerous neurological diseases and nervous system lesions are still incurable. To improve the survival and quality of life of patients, current therapeutic developments are essentially based on three strategies: prevent the loss of neurons by using anti-apoptotic compounds, optimise the action of surviving cells using chemical additives, regenerate the nervous system in a non-specific manner or by grafting new neurons.
Though the symptoms of the disease can sometimes be offset for a short period, these treatments nevertheless only have a moderate effect and often induce strong side effects.

By helping to identify the mechanisms responsible for nervous system mobility and plasticity, the founding scientists of Pharmaxon have opened the way to a new neuropharmacology that aims at modulating nerve cell mobility, the cause or consequence of most of these complex, multifactorial diseases. 

Through its new class of products, Pharmaxon intends to stimulate the natural mechanisms of regeneration (in neurodegenerative diseases or traumatic injuries of the nervous system), or block tumor growth and spread (in brain tumors) by guaranteeing a minimum of toxicity.